Eupraxia Pharmaceuticals USA LLC has a total of 23 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Australia and China. Its main competitors in its focus markets pharmaceuticals are PETRELLA ROBERT JOHN, RAMSCOR INC and WEDGE STEPHEN ROBERT.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 2 | |
#3 | China | 2 | |
#4 | Japan | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Singapore | 2 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Chile | 1 | |
#10 | EPO (European Patent Office) | 1 | |
#11 | Hong Kong | 1 | |
#12 | Mexico | 1 | |
#13 | New Zealand | 1 | |
#14 | Taiwan | 1 | |
#15 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Smith Thomas J | 20 |
#2 | Malone Amanda M | 18 |
#3 | Helliwell James A | 18 |
#4 | Baum Marc M | 18 |
#5 | Marc M Baum | 4 |
#6 | Amanda M Malone | 4 |
#7 | James A Helliwell | 4 |
#8 | Thomas J Smith | 2 |
#9 | Baum Marc | 1 |
#10 | Helliwell James | 1 |
Publication | Filing date | Title |
---|---|---|
US2014287053A1 | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |